MEDTRONIC REPORTS SECOND QUARTER FINANCIAL RESULTS
Revenue of $7.5 Billion Increased 6.1% Reported; Increased 7.5% Organic
GAAP Diluted EPS of $0.82; Non-GAAP Diluted EPS of $1.22
Cash Flow from Operations of $2.9 Billion in First Six Months vs. $1.6 Billion in Prior Year;
Free Cash Flow of $2.4 Billion in First Six Months vs. $1.1 Billion in Prior Year
Company Increases FY19 Organic Revenue Growth Guidance
“This was an outstanding quarter for Medtronic. We are executing on multiple fronts, resulting in robust top-line growth, solid margin expansion, and increasing free cash flow,” said Omar Ishrak, Medtronic chairman and chief executive officer. “Yet, even more exciting than our results this quarter is the progress we are making on our new product pipeline,
which is stronger than at any time in our company’s history.”
http://phx.corporate-ir.net/External.File?t=1&item=VHlwZT0yfFBhcmVudElEPTUyNjg1Nzh8Q2hpbGRJRD03MDIwODc=
